Donate now!

Philanthropy is crucial to support our mission and serve our patients. Every gift counts, no matter the size. Below you can find a list of recent publications by our talented and diverse faculty. Click here to contribute! Thank you for your consideration.

Recent Publications

• Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
  Cousins KAQ, Phillips JS, Das SR, O'Brien K, Tropea TF, Chen-Plotkin A, Shaw LM, Nasrallah IM, Mechanic-Hamilton D, McMillan CT, Irwin DJ, Lee EB, Wolk DA Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024 Apr 21;
• In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database.
  Mantri S, Purks JL, Kinel D, Arbatti L, Hosamath A, Allen A, Amara A, Anderson K, Chahine LM, Eberly S, Mathur S, Standaert D, Oakes D, Weintraub D, Shoulson I, Marras C Journal of Parkinson's disease. 2024 Apr 21;
• GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
  Brody EM, Seo Y, Suh E, Amari N, Hartstone WG, Skrinak RT, Zhang H, Diaz-Ortiz ME, Weintraub D, Tropea TF, Van Deerlin VM, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2024 Apr 12;
• Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
  Weintraub D, Marras C, Amara A, Anderson KE, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Shoulson I, Arbatti L Movement disorders : official journal of the Movement Disorder Society. 2024 Apr;39(4):706-714 Epub 2024 Feb 6;
• Disparities in Genetic Testing for Neurologic Disorders.
  Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA Neurology. 2024 Mar 26;102(6):e209161 Epub 2024 Mar 6;
• Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
  Reus LM, Jansen IE, Tijms BM, Visser PJ, Tesi N, van der Lee SJ, Vermunt L, Peeters CFW, De Groot LA, Hok-A-Hin YS, Chen-Plotkin A, Irwin DJ, Hu WT, Meeter LH, van Swieten JC, Holstege H, Hulsman M, Lemstra AW, Pijnenburg YAL, van der Flier WM, Teunissen CE, Del Campo Milan M Brain : a journal of neurology. 2024 Mar 25;
• Integration of natural selection across the life cycle stabilizes a marine mussel hybrid zone.
  Willis AB, Ermolaeva E, Zyck A, Rognstad R, Davis S, Hilbish TJ Ecology and evolution. 2024 Mar;14(3):e11086 Epub 2024 Mar 10;
• A structured, journal-led peer-review mentoring program enhances peer review training.
  Lyons-Warren AM, Aamodt WW, Pieper KM, Strowd RE Research integrity and peer review. 2024 Mar 8;9(1):3;
• Novel computerized measure of apathy associates with care partner burden and instrumental activities of daily living in Parkinson's disease.
  Liu J, Massimo L, McMillan CT, Dahodwala N Parkinsonism & related disorders. 2024 Mar;120:105983 Epub 2024 Jan 3;
• Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment.
  Kawabata K, Djamshidian A, Bagarinao E, Weintraub D, Seppi K, Poewe W Parkinsonism & related disorders. 2024 Mar;120:105984 Epub 2023 Dec 28;
• Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.
  Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, Phillips JS, McMillan CT, Luk KC, Deik A, Spindler MA, Tropea TF, Weintraub D, Wolk DA, Grossman M, Lee V, Chen-Plotkin AS, Lee EB, Irwin DJ Annals of clinical and translational neurology. 2024 Mar;11(3):673-685 Epub 2024 Jan 23;
• Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017-2022.
  Aamodt WW, Kluger BM, Mirham M, Job A, Lettenberger SE, Mosley PE, Seshadri S Journal of geriatric psychiatry and neurology. 2024 Mar;37(2):96-113 Epub 2023 Aug 8;
• Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
  Marras C, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, Van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Mollenhauer B, Postuma RB, Rodríguez-Violante M, Simuni T, Weintraub D, Lawton M, Mestre TA Movement disorders : official journal of the Movement Disorder Society. 2024 Mar;39(3):462-471 Epub 2024 Jan 20;
• Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
  Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM, ASPEN-1 Study Group Neurology. 2024 Feb 27;102(4):e208091 Epub 2024 Jan 31;
• Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial.
  Weintraub D, Espay AJ, Sharma VD, Tariot PN, Abler V, Pathak S, Stankovic S Parkinsonism & related disorders. 2024 Feb;119:105951 Epub 2023 Dec 12;
• Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus.
  Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, Lang AE, Martinez Martin P, Rodríguez-Oroz MC, Weintraub D, Krack P, Deuschl G, and the Members of the ICBD in PD Management Consensus Group Movement disorders : official journal of the Movement Disorder Society. 2024 Feb;39(2):235-248 Epub 2024 Jan 17;
• Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts.
  Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA Journal of neurology. 2024 Feb;271(2):733-747 Epub 2023 Oct 27;
• Evaluation of ATN(PD) Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.
  Cousins KAQ, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, Galasko D, Hutten S, Weintraub D, Siderowf AD, Marek K, Poston KL, Shaw LM, Parkinson's Progression Markers Initiative Neurology. 2024 Feb;102(4):e208033 Epub 2024 Feb 2;
• A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
  Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K The Lancet. Neurology. 2024 Feb;23(2):178-190;
• Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's Disease.
  Shantaraman A, Dammer EB, Ugochukwu O, Duong DM, Yin L, Carter EK, Gearing M, Chen-Plotkin A, Lee EB, Trojanowski JQ, Bennett DA, Lah JJ, Levey AI, Seyfried NT, Higginbotham L bioRxiv : the preprint server for biology. 2024 Jan 24;
• Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohort.
  Maggi G, Vitale C, Giacobbe C, Barone A, Mastromarino C, Iannotta F, Amboni M, Weintraub D, Santangelo G Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024 Jan 17;
• Social Determinants of Health in Idiopathic Intracranial Hypertension.
  Markowitz D, Aamodt WW, Hamedani AG Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024 Jan 3;
• Ethnoracial differences for caregiving burden in Parkinson's disease.
  Bayram E, Liu H, Luo S, Di Luca DG, Skipworth M, Damron Solomon L, Dahodwala N, Litvan I Parkinsonism & related disorders. 2024 Jan;118:105927 Epub 2023 Nov 7;
• Parkinson's Disease and Dementia with Lewy Bodies: One and the Same.
  Borghammer P, Okkels N, Weintraub D Journal of Parkinson's disease. 2024;14(3):383-397;
• Spirituality and Spiritual Distress in Parkinson's Disease Caregivers: A Scoping Review.
  Seshadri S, Sugiura K, Mirham M, Aamodt WW, Kluger BM Journal of religion and health. 2023 Dec;62(6):4222-4243 Epub 2023 Sep 13;
• Nationwide emergency department visits for pediatric traumatic spinal cord injury in the United States, 2016-2020.
  Crispo JAG, Liu LJW, Noonan VK, Thorogood NP, Kwon BK, Dvorak MF, Thibault D, Willis AW, Cragg JJ Frontiers in neurology. 2023;14:1264589 Epub 2023 Nov 10;
• Preimplantation Genetic Testing for Adult-Onset Neurodegenerative Disease: Considerations for Access, Utilization, and Counseling.
  Paul RA, Baldwin A, Johnson K, Manning Peskin S, Tropea TF, Azage M, Bardakjian T, Dratch L Neurology. 2023 Nov 7;101(19):836-841 Epub 2023 Aug 18;
• Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms.
  Chahine LM, Arbatti L, Hosamath A, Amara A, Anderson KE, Purks J, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C Clinical parkinsonism & related disorders. 2023;9:100229 Epub 2023 Nov 7;
• Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays.
  Tropea TF, Kannarkat GT, Shaw LM Clinical chemistry. 2023 Nov 2;69(11):1209-1211;
• CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
  van der Ende EL, In 't Veld SGJG, Hanskamp I, van der Lee S, Dijkstra JIR, Hok-A-Hin YS, Blujdea ER, van Swieten JC, Irwin DJ, Chen-Plotkin A, Hu WT, Lemstra AW, Pijnenburg YAL, van der Flier WM, Del Campo M, Teunissen CE, Vermunt L Brain : a journal of neurology. 2023 Nov 2;146(11):4495-4507;
• Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.
  Kang JH, Korecka M, Lee EB, Cousins KAQ, Tropea TF, Chen-Plotkin AA, Irwin DJ, Wolk D, Brylska M, Wan Y, Shaw LM Clinical chemistry. 2023 Nov 2;69(11):1247-1259;
• What's in a Name? The Time Has Come to Unify Parkinson's Disease and Dementia with Lewy Bodies.
  Weintraub D Movement disorders : official journal of the Movement Disorder Society. 2023 Nov;38(11):1977-1981 Epub 2023 Aug 23;
• Health equity integrated epilepsy care and research: A narrative review.
  Gotlieb EG, Blank L, Willis AW, Agarwal P, Jette N Epilepsia. 2023 Nov;64(11):2878-2890 Epub 2023 Sep 19;
• α-synuclein seed amplification in Parkinson's disease - Authors' reply.
  Siderowf A, Concha-Marambio L, Marek K, Soto C The Lancet. Neurology. 2023 Nov;22(11):985-986;
• The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP).
  Koneru V, Espay AJ, Cole AJ, Weintraub D, Crist K, Pascual MB, Ondo WG Movement disorders : official journal of the Movement Disorder Society. 2023 Nov;38(11):1982-1987 Epub 2023 Nov 8;
• Clinical Reasoning: A 48-Year-Old Man With Spasticity and Progressive Ataxia.
  Vizcarra JA, Paul RA, Hamedani AG, Lynch DR, Aamodt WW Neurology. 2023 Oct 24;101(17):e1747-e1752 Epub 2023 Aug 18;
• Unique characteristics of end-of-life hospitalizations in Parkinson disease.
  Aamodt WW, Dahodwala N, Bilker WB, Farrar JT, Willis AW Frontiers in aging neuroscience. 2023;15:1254969 Epub 2023 Oct 12;
• Testing for Allele-specific Expression from Human Brain Samples.
  Diaz-Ortiz ME, Jain N, Gallagher MD, Posavi M, Unger TL, Chen-Plotkin AS Bio-protocol. 2023 Oct 5;13(19):e4832;
• Social Control and Health Behaviors Among Individuals Living with Parkinson's Disease: A Pilot Study.
  Mavandadi S, Interian A, Sayers S, Dobkin R, Weintraub D International journal of behavioral medicine. 2023 Oct 2;
• Nationwide trends in emergency department utilisation for acute retinal ischaemia in the USA, 2011-2018.
  Hamedani AG, De Lott LB, Willis AW The British journal of ophthalmology. 2023 Oct;107(10):1490-1495 Epub 2022 Jun 27;
• Weight and survival after deep brain stimulation for Parkinson's disease.
  Eisinger RS, Okun MS, Cernera S, Cagle J, Beke M, Ramirez-Zamora A, Kim BH, Barbosa DAN, Qiu L, Vaswani P, Aamodt WW, Halpern CH, Foote KD, Gunduz A, Almeida L Parkinsonism & related disorders. 2023 Oct;115:105810 Epub 2023 Aug 18;
• Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease.
  Abraham DS, Pham Nguyen TP, Newcomb CW, Gray SL, Hennessy S, Leonard CE, Liu Q, Weintraub D, Willis AW Parkinsonism & related disorders. 2023 Oct;115:105822 Epub 2023 Sep 4;
• Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study.
  Gallagher J, Mamikonyan E, Xie SX, Tran B, Shaw S, Weintraub D Scientific reports. 2023 Sep 27;13(1):16243;
• CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
  Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE Nature communications. 2023 Sep 13;14(1):5635;
• Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom Burden.
  Hamedani AG, Auinger P, Willis AW, Safarpour D, Shprecher D, Stover N, Subramanian T, Cloud L Movement disorders : official journal of the Movement Disorder Society. 2023 Sep;38(9):1679-1687 Epub 2023 Jun 15;
• Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial.
  Fernandez HH, Weintraub D, Macklin E, Litvan I, Schwarzschild MA, Eberling J, Videnovic A, Kenney CJ, Parkinson Study Group SYNAPSE Investigators Parkinsonism & related disorders. 2023 Sep;114:105511 Epub 2023 Jul 13;
• Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury.
  Pham Nguyen TP, Gray SL, Newcomb CW, Liu Q, Hamedani AG, Weintraub D, Hennessy S, Willis AW Parkinsonism & related disorders. 2023 Sep;114:105793 Epub 2023 Aug 6;
• Disease Progression and Sphingolipids and Neurofilament Light Chain in Early Idiopathic Parkinson's Disease.
  Couto B, Sousa M, Gonzalez-Latapi P, McArthur E, Lang A, Chen-Plotkin A, Marras C The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2023 Aug 29;:1-4;
• Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease.
  Aamodt WW, Bilker WB, Willis AW, Farrar JT Neurology. Clinical practice. 2023 Aug;13(4):e200171 Epub 2023 May 25;
• Association of Caregiver Depression Risk With Patient Outcomes in Parkinson Disease.
  Rashid R, Aamodt WW, Horn S, Dahodwala N JAMA network open. 2023 Aug 1;6(8):e2327485;
• Care access and utilization among medicare beneficiaries living with Parkinson's disease.
  Pearson C, Hartzman A, Munevar D, Feeney M, Dolhun R, Todaro V, Rosenfeld S, Willis A, Beck JC NPJ Parkinson's disease. 2023 Jul 10;9(1):108;
• Dopamine agonists and risk of lung cancer in patients with restless legs syndrome.
  Hernandez-Con P, Shults J, Willis AW, Yang YX Pharmacoepidemiology and drug safety. 2023 Jul;32(7):726-734 Epub 2023 Feb 21;
• Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
  Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodríguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS, International Parkinson and Movement Disorders Society Non-Motor Parkinson Disease Study Group Movement disorders : official journal of the Movement Disorder Society. 2023 Jul;38(7):1236-1252 Epub 2023 May 5;
• Validation of the Rainbow Model of Integrated Care Measurement Tool in Parkinson's Disease.
  Valentijn PP, Eggers C, Bloem BR, Grimes D, Goldman J, McGinley J, Gardner J, Piemonte MEP, Dahodwala N, Brennan L, Iansek R, Kovacs N, Parashos S, Hilel A, Rajan R, MDS Study Group on Management of Movement Disorders: Interdisciplinary and Integrated Care Movement disorders : official journal of the Movement Disorder Society. 2023 Jul;38(7):1253-1261 Epub 2023 May 6;
• The Water, the Air, the Marines-Camp Lejeune, Trichloroethylene, and Parkinson Disease.
  Dorsey ER, Greenamyre JT, Willis AW JAMA neurology. 2023 Jul 1;80(7):663-665;
• Predictive value of abbreviated olfactory tests in prodromal Parkinson disease.
  Vaswani PA, Morley JF, Jennings D, Siderowf A, Marek K, PARS Investigators NPJ Parkinson's disease. 2023 Jun 29;9(1):103;
• Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.
  Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A, Members of the IPMDS Rating Scales Review Committee Movement disorders : official journal of the Movement Disorder Society. 2023 Jun;38(6):1008-1026 Epub 2023 Apr 20;
• Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
  Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, Irwin DJ, McMillan CT, Wolk DA, Chen-Plotkin A, Weintraub D, Schuck T, Lee VMY, Trojanowski JQ, Lee EB Brain : a journal of neurology. 2023 Jun 1;146(6):2557-2569;
• Linked Patient and Provider Impressions of Outpatient Teleneurology Encounters.
  James JG, Park J, Oliver A, Xie SX, Siderowf A, Spindler M, Wechsler LR, Tropea TF Neurology. Clinical practice. 2023 Jun;13(3):e200159 Epub 2023 May 1;
• Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence.
  Di Luca DG, Luo S, Liu H, Cohn M, Davis TL, Ramirez-Zamora A, Rafferty M, Dahodwala N, Naito A, Neault M, Beck J, Marras C Neurology. 2023 May 23;100(21):e2170-e2181 Epub 2023 Apr 5;
• Cognitive heterogeneity in Parkinson's disease: A mechanistic view.
  Carceles-Cordon M, Weintraub D, Chen-Plotkin AS Neuron. 2023 May 17;111(10):1531-1546 Epub 2023 Apr 6;
• Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications.
  Hernandez-Con P, Lin I, Mamikonyan E, Deeb W, Feldman R, Althouse A, Barmore R, Eisinger RS, Spindler M, Okun MS, Weintraub D, Chahine LM Movement disorders clinical practice. 2023 Jun;10(6):903-913 Epub 2023 May 5;
• Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
  Nilsson J, Cousins KAQ, Gobom J, Portelius E, Chen-Plotkin A, Shaw LM, Grossman M, Irwin DJ, Trojanowski JQ, Zetterberg H, Blennow K, Brinkmalm A Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023 May;19(5):1775-1784 Epub 2022 Oct 14;
• Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.
  Tropea TF, Albuja I, Cousins KAQ, Irwin DJ, Lee EB, Chen-Plotkin AS Annals of neurology. 2023 May;93(5):1045-1046 Epub 2023 Mar 16;
• Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease.
  Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF Annals of clinical and translational neurology. 2023 May;10(5):802-813 Epub 2023 Mar 31;
• Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
  Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson's Progression Markers Initiative The Lancet. Neurology. 2023 May;22(5):407-417;
• Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic.
  Deik A Journal of movement disorders. 2023 May;16(2):158-162 Epub 2023 May 24;
• Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
  Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Simuni T, Siderowf A, Singleton A, Seibyl J, Tanner CM, Parkinson's Progression Markers Initiative Movement disorders clinical practice. 2023 Jun;10(6):943-955 Epub 2023 Apr 25;
• Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration.
  Neel DV, Basu H, Gunner G, Bergstresser MD, Giadone RM, Chung H, Miao R, Chou V, Brody E, Jiang X, Lee E, Watts ME, Marques C, Held A, Wainger B, Lagier-Tourenne C, Zhang YJ, Petrucelli L, Young-Pearse TL, Chen-Plotkin AS, Rubin LL, Lieberman J, Chiu IM Neuron. 2023 Apr 19;111(8):1222-1240.e9 Epub 2023 Mar 13;
• Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older.
  Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K Neurology. 2023 Apr 18;100(16):e1691-e1701 Epub 2023 Feb 27;
• Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study.
  Adams JL, Kangarloo T, Tracey B, O'Donnell P, Volfson D, Latzman RD, Zach N, Alexander R, Bergethon P, Cosman J, Anderson D, Best A, Severson J, Kostrzebski MA, Auinger P, Wilmot P, Pohlson Y, Waddell E, Jensen-Roberts S, Gong Y, Kilambi KP, Herrero TR, Ray Dorsey E, Parkinson Study Group Watch-PD Study Investigators and Collaborators NPJ Parkinson's disease. 2023 Apr 17;9(1):64;
• Racial and Ethnic Disparities in Parkinson Disease: A Call to Action.
  Aamodt WW, Willis AW, Dahodwala N Neurology. Clinical practice. 2023 Apr;13(2):e200138 Epub 2023 Mar 16;
• Seasonal Variation in Neurologic Hospitalizations in the United States.
  Hamedani AG, Thibault D, Willis AW Annals of neurology. 2023 Apr;93(4):743-751 Epub 2022 Dec 25;
• The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease.
  Speelberg DHB, Hulshoff MJ, Book E, Dahodwala N, Korell M, Tanner CM, Marras C Movement disorders clinical practice. 2023 Apr;10(4):596-605 Epub 2023 Mar 11;
• Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies.
  Abraham DS, Nguyen TPP, Blank LJ, Thibault D, Gray SL, Hennessy S, Leonard CE, Weintraub D, Willis AW Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2023 Mar;20(2):375-388 Epub 2023 Mar 2;
• LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
  Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B, Siderowf A, Tanner C, Marek K, the Parkinson’s Progression Markers Initiative NPJ Parkinson's disease. 2023 Feb 28;9(1):30;
• Strategic Utilization of Next-Generation Deep Brain Stimulation Pulse Generators.
  Qiu L, Spindler M, Halpern CH Movement disorders clinical practice. 2023 Apr;10(4):722-723 Epub 2023 Feb 28;
• Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study.
  Weintraub D, Gallagher J, Mamikonyan E, Xie S, Tran B, Shaw S Research square. 2023 Feb 7;
• Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease.
  Miller-Patterson C, Hsu JY, Willis AW, Hamedani AG JAMA neurology. 2023 Feb 1;80(2):200-204;
• Plasma phosphorylated tau181 predicts cognitive and functional decline.
  Tropea TF, Waligorska T, Xie SX, Nasrallah IM, Cousins KAQ, Trojanowski JQ, Grossman M, Irwin DJ, Weintraub D, Lee EB, Wolk DA, Chen-Plotkin AS, Shaw LM, Alzheimer's Disease Neuroimaging Initiative Annals of clinical and translational neurology. 2023 Jan;10(1):18-31 Epub 2022 Dec 14;
• Challenges in the study of individuals at risk for Parkinson disease.
  Marras C, Alcalay RN, Siderowf A, Postuma RB Handbook of clinical neurology. 2023;192:219-229;
• Proposal for a Biologic Staging System of Parkinson's Disease.
  Chahine LM, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K, Simuni T Journal of Parkinson's disease. 2023;13(3):297-309;
• What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP).
  Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, Shoulson I Journal of Parkinson's disease. 2023;13(5):757-767;
• Parkinson's Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson's Disease.
  Garg U, Gujral J, Gandhi OH, Dahodwala N, Goldner LJ, Hughes S, Reichwein S, Zelouf L, Aamodt WW Journal of Parkinson's disease. 2023;13(7):1267-1271;
• Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.
  Acton EK, Willis AW, Hennessy S Pharmacoepidemiology and drug safety. 2023 Jan;32(1):9-18 Epub 2022 Oct 20;
• Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.
  Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS, Parkinson’s Progression Markers Initiative Journal of Parkinson's disease. 2023;13(6):899-916;
• Interfacility Transfers for Seizure-Related Emergencies in the United States.
  Acton EK, Blank LJ, Willis AW, Hamedani AG Neurology. 2022 Dec 12;99(24):e2718-e2727;
• Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
  Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA The Lancet. Neurology. 2022 Dec;21(12):1099-1109;
• Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.
  Miller-Patterson C, Hsu JY, Chahine LM, Morley JF, Willis AW Clinical autonomic research : official journal of the Clinical Autonomic Research Society. 2022 Dec;32(6):463-476 Epub 2022 Sep 3;
• Hallucinations, Antipsychotic Use, and Mortality in Older Adults with Dementia: Retrospective Cohort Study of Two Medicare-Linked National Health Surveys.
  Hamedani AG, Weintraub D, Willis AW Drugs & aging. 2022 Dec;39(12):967-974 Epub 2022 Dec 2;
• Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.
  Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L, Pizzo D, Weintraub D, Siderowf A, Litvan I, Rissman RA, Galasko D, Hansen L, Trojanowski JQ, Lee E, Grossman M, Irwin D Journal of neuropathology and experimental neurology. 2022 Nov 16;81(12):953-964;
• CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology.
  Cousins KAQ, Arezoumandan S, Shellikeri S, Ohm D, Shaw LM, Grossman M, Wolk D, McMillan CT, Chen-Plotkin A, Lee E, Trojanowski JQ, Zetterberg H, Blennow K, Irwin DJ Neurology. 2022 Nov 14;99(20):e2303-e2312;
• RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus.
  O'Brien JT, Chouliaras L, Sultana J, Taylor JP, Ballard C, RENEWAL Study Group Alzheimer's research & therapy. 2022 Nov 11;14(1):169;
• Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.
  Cousins KAQ, Shaw LM, Shellikeri S, Dratch L, Rosario L, Elman LB, Quinn C, Amado DA, Wolk DA, Tropea TF, Chen-Plotkin A, Irwin DJ, Grossman M, Lee EB, Trojanowski JQ, McMillan CT Annals of neurology. 2022 Nov;92(5):807-818 Epub 2022 Aug 17;
• Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.
  Vaswani PA, Morley JF, Jennings D, Siderowf A, Marek K, PARS investigators Parkinsonism & related disorders. 2022 Nov;104:15-20 Epub 2022 Sep 17;
• Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
  Cousins KAQ, Shaw LM, Chen-Plotkin A, Wolk DA, Van Deerlin VM, Lee EB, McMillan CT, Grossman M, Irwin DJ JAMA neurology. 2022 Nov 1;79(11):1155-1164;
• CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels.
  Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, Seyfried NT, Dammer EB, Herradon G, Meeter LH, van Swieten J, Alcolea D, Lleó A, Levey AI, Lemstra AW, Pijnenburg YAL, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE Nature aging. 2022 Nov;2(11):1040-1053 Epub 2022 Nov 10;
• Management of psychiatric and cognitive complications in Parkinson's disease.
  Weintraub D, Aarsland D, Biundo R, Dobkin R, Goldman J, Lewis S BMJ (Clinical research ed.). 2022 Oct 24;379:e068718;
• Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
  Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s Progression Marker Initiative Authors NPJ Parkinson's disease. 2022 Oct 22;8(1):140;
• Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
  Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM, SPARX3-PSG Investigators Trials. 2022 Oct 6;23(1):855;
• Atypical antipsychotic use and mortality risk in Parkinson disease.
  Pham Nguyen TP, Thibault D, Hamedani AG, Weintraub D, Willis AW Parkinsonism & related disorders. 2022 Oct;103:17-22 Epub 2022 Aug 19;
• Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies.
  Weintraub D, Irwin D Continuum (Minneapolis, Minn.). 2022 Oct 1;28(5):1314-1332;
• [(18)F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson's Disease.
  Doot RK, Young AJ, Nasrallah IM, Wetherill RR, Siderowf A, Mach RH, Dubroff JG Cells. 2022 Sep 30;11(19);
• Amphetamine-related care in the USA, 2003-2014: cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes.
  Liu LJW, Crispo JAG, Bach P, Ansell DR, Thibault D, Willis AW, Cragg JJ BMJ open. 2022 Sep 20;12(9):e059898;
• Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors.
  Atri R, Urban K, Marebwa B, Simuni T, Tanner C, Siderowf A, Frasier M, Haas M, Lancashire L Sensors (Basel, Switzerland). 2022 Sep 9;22(18);
• Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
  Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y, Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D, Grossman M, Nevler N Parkinsonism & related disorders. 2022 Sep;102:94-100 Epub 2022 Aug 6;
• GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
  Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS Science (New York, N.Y.). 2022 Aug 19;377(6608):eabk0637;
• Changing of the Guard: The Neurology® Resident & Fellow Section in 2022 and Beyond.
  Aamodt WW, Fu KA, Lyons-Warren AM Neurology. 2022 Aug 16;99(7):265-266;
• Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures.
  Mirelman A, Siderowf A, Chahine L Neurology. 2022 Aug 16;99(7 Suppl 1):52-60;
• Characterization of Non-Motor Fluctuations Using the Movement Disorder Society Non-Motor Rating Scale.
  van Wamelen DJ, Rota S, Schrag A, Rizos A, Martinez-Martin P, Weintraub D, Ray Chaudhuri K Movement disorders clinical practice. 2022 Oct;9(7):932-940 Epub 2022 Aug 5;
• Trial of Cinpanemab in Early Parkinson's Disease.
  Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T, SPARK Investigators The New England journal of medicine. 2022 Aug 4;387(5):408-420;
• Trial of Prasinezumab in Early-Stage Parkinson's Disease.
  Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A, PASADENA Investigators, Prasinezumab Study Group The New England journal of medicine. 2022 Aug 4;387(5):421-432;
• Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
  Shen J, Amari N, Zack R, Skrinak RT, Unger TL, Posavi M, Tropea TF, Xie SX, Van Deerlin VM, Dewey RB Jr, Weintraub D, Trojanowski JQ, Chen-Plotkin AS Annals of neurology. 2022 Aug;92(2):255-269 Epub 2022 Jun 7;
• Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age.
  Zuroff L, Rezk A, Shinoda K, Espinoza DA, Elyahu Y, Zhang B, Chen AA, Shinohara RT, Jacobs D, Alcalay RN, Tropea TF, Chen-Plotkin A, Monsonego A, Li R, Bar-Or A EBioMedicine. 2022 Aug;82:104179 Epub 2022 Jul 19;
• Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline.
  Zuroff L, Wisse LE, Glenn T, Xie SX, Nasrallah IM, Habes M, Dubroff J, de Flores R, Xie L, Yushkevich P, Doshi J, Davatsikos C, Shaw LM, Tropea TF, Chen-Plotkin AS, Wolk DA, Das S, Mechanic-Hamilton D Journal of Alzheimer's disease reports. 2022;6(1):411-430 Epub 2022 Jul 22;
• Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
  Tosun D, Demir Z, Veitch DP, Weintraub D, Aisen P, Jack CR Jr, Jagust WJ, Petersen RC, Saykin AJ, Shaw LM, Trojanowski JQ, Weiner MW, Alzheimer's Disease Neuroimaging Initiative Alzheimer's & dementia : the journal of the Alzheimer's Association. 2022 Jul;18(7):1370-1382 Epub 2021 Oct 14;
• Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset.
  Wyman-Chick KA, O'Keefe LR, Weintraub D, Armstrong MJ, Rosenbloom M, Martin PK, Barclay TR, Barrett MJ Journal of geriatric psychiatry and neurology. 2022 Jul;35(4):527-534 Epub 2021 Jun 11;
• Genetic prediction of impulse control disorders in Parkinson's disease.
  Weintraub D, Posavi M, Fontanillas P, Tropea TF, Mamikonyan E, Suh E, Trojanowski JQ, Cannon P, Van Deerlin VM, 23andMe Research Team, Chen-Plotkin AS Annals of clinical and translational neurology. 2022 Jul;9(7):936-949 Epub 2022 Jun 27;
• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers.
  Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, Irwin DJ Parkinsonism & related disorders. 2022 Jul;100:33-36 Epub 2022 Jun 8;
• Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson's Disease.
  Liu W, Liu J, Bhavsar R, Mao T, Mamikonyan E, Raizen D, Detre JA, Weintraub D, Rao H Frontiers in aging neuroscience. 2022;14:901203 Epub 2022 Jun 10;
• Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
  Jennings D, Huntwork-Rodriguez S, Henry AG, Sasaki JC, Meisner R, Diaz D, Solanoy H, Wang X, Negrou E, Bondar VV, Ghosh R, Maloney MT, Propson NE, Zhu Y, Maciuca RD, Harris L, Kay A, LeWitt P, King TA, Kern D, Ellenbogen A, Goodman I, Siderowf A, Aldred J, Omidvar O, Masoud ST, Davis SS, Arguello A, Estrada AA, de Vicente J, Sweeney ZK, Astarita G, Borin MT, Wong BK, Wong H, Nguyen H, Scearce-Levie K, Ho C, Troyer MD Science translational medicine. 2022 Jun 8;14(648):eabj2658;
• Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting.
  Blömeke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamgüney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D NPJ Parkinson's disease. 2022 Jun 2;8(1):68;
• John Q. Trojanowski, 'tour de force' in neurodegeneration (1946-2022).
  Chen-Plotkin AS Nature neuroscience. 2022 Jun;25(6):675-676;
• Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals.
  Acton EK, Hennessy S, Brensinger CM, Bilker WB, Miano TA, Dublin S, Horn JR, Chung S, Wiebe DJ, Willis AW, Leonard CE Frontiers in pharmacology. 2022;13:845485 Epub 2022 May 10;
• Readmission Following Hospitalization for Traumatic Brain Injury: A Nationwide Study.
  Kelly DJ, Thibault D, Tam D, Liu LJW, Cragg JJ, Willis AW, Crispo JAG The Journal of head trauma rehabilitation. 2022 May-Jun 01;37(3):E165-E174 Epub 2021 Jun 15;
• Prosodic characteristics of prepausal words produced by patients with neurodegenerative disease.
  Cho S, Agmon G, Shellikeri S, Cousins KAQ, Ash S, Irwin DJ, Spindler M, Deik AF, Elman LB, Quinn C, Liberman M, Grossman M, Nevler N Speech prosody (Urbana, Ill.). 2022 May;2022:120-124;
• Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.
  Boel JA, de Bie RMA, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ, MDS Study Group Mild Cognitive Impairment in Parkinson's Disease Movement disorders clinical practice. 2022 May;9(4):479-483 Epub 2022 Apr 29;
• Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism.
  Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF NPJ Parkinson's disease. 2022 Apr 28;8(1):53;
• Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
  Decker BM, Thibault D, Davis KA, Willis AW Neurology. 2022 Apr 12;98(15):e1545-e1554 Epub 2022 Feb 15;
• Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
  Cervantes González A, Irwin DJ, Alcolea D, McMillan CT, Chen-Plotkin A, Wolk D, Sirisi S, Dols-Icardo O, Querol-Vilaseca M, Illán-Gala I, Santos-Santos MA, Fortea J, Lee EB, Trojanowski JQ, Grossman M, Lleó A, Belbin O Molecular neurodegeneration. 2022 Apr 8;17(1):29;
• Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.
  Ellis DE, Hubbard RA, Willis AW, Zuppa AF, Zaoutis TE, Hennessy S Pharmacoepidemiology and drug safety. 2022 Apr;31(4):393-403 Epub 2021 Dec 28;
• Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study.
  Sanchez AV, Ison JM, Hemley H, Willis A, Siddiqi B, Macklin EA, Ulysse C, Reynolds M, Schwarzschild MA, Jackson JD Contemporary clinical trials. 2022 Apr;115:106713 Epub 2022 Feb 22;
• Resident & Fellow Rounds: March 2022.
  Strowd RE 3rd, Aamodt W Neurology. 2022 Mar 29;98(13):540-542;
• Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
  Takahashi M, Koh J, Yorozu S, Kajimoto Y, Nakayama Y, Sakata M, Yasui M, Hiwatani Y, Weintraub D, Ito H Parkinson's disease. 2022;2022:1503167 Epub 2022 Mar 23;
• Provider Experience with Teleneurology in an Academic Neurology Department.
  Tropea TF, Fuentes A, Roberts Z, Spindler M, Yuan K, Perrone C, Do D, Jacobs D, Wechsler L Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2022 Mar;28(3):374-383 Epub 2021 Jun 1;
• Medicare Claims Data Underestimate Hallucinations in Older Adults With Dementia.
  Hamedani AG, Weintraub D, Willis AW The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2022 Mar;30(3):352-359 Epub 2021 Aug 5;
• Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease.
  Guttuso T Jr, Sirica D, Tosun D, Zivadinov R, Pasternak O, Weintraub D, Baglio F, Bergsland N Movement disorders : official journal of the Movement Disorder Society. 2022 Mar;37(3):490-501 Epub 2021 Dec 22;
• Signature laminar distributions of pathology in frontotemporal lobar degeneration.
  Ohm DT, Cousins KAQ, Xie SX, Peterson C, McMillan CT, Massimo L, Raskovsky K, Wolk DA, Van Deerlin VM, Elman L, Spindler M, Deik A, Trojanowski JQ, Lee EB, Grossman M, Irwin DJ Acta neuropathologica. 2022 Mar;143(3):363-382 Epub 2022 Jan 8;
• Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic.
  Ellis DE, Hubbard RA, Willis AW, Zuppa AF, Zaoutis TE, Hennessy S Diabetes research and clinical practice. 2022 Mar;185:109225 Epub 2022 Feb 3;
• Resident & Fellow Rounds: February 2022.
  Strowd RE 3rd, Aamodt W Neurology. 2022 Feb 22;98(8):327-329;
• Adverse Childhood Experiences in Patients With Neurologic Disease.
  Mendizabal A, Nathan CL, Khankhanian P, Anto M, Clyburn C, Acaba-Berrocal A, Breen L, Dahodwala N Neurology. Clinical practice. 2022 Feb;12(1):60-67;
• Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".
  Aamodt WW, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2022 Feb;37(2):436-437;
• The neuropsychiatry of Parkinson's disease: advances and challenges.
  Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, Schrag A The Lancet. Neurology. 2022 Jan;21(1):89-102;
• Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer's Disease to Parkinson's Disease.
  Weinshel S, Irwin DJ, Zhang P, Weintraub D, Shaw LM, Siderowf A, Xie SX Journal of Parkinson's disease. 2022;12(4):1155-1167;
• A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson's Disease: A Qualitative Study.
  Staunton H, Kelly K, Newton L, Leddin M, Rodriguez-Esteban R, Chaudhuri KR, Weintraub D, Postuma RB, Martinez-Martin P Journal of Parkinson's disease. 2022;12(1):137-151;
• Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
  Uemura MT, Robinson JL, Cousins KAQ, Tropea TF, Kargilis DC, McBride JD, Suh E, Xie SX, Xu Y, Porta S, Uemura N, Van Deerlin VM, Wolk DA, Irwin DJ, Brunden KR, Lee VM, Lee EB, Trojanowski JQ Acta neuropathologica. 2022 Jan;143(1):15-31 Epub 2021 Dec 2;
• Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.
  Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW, Parkinson’s Progression Markers Initiative Journal of Parkinson's disease. 2022;12(1):421-436;
• Pediatric Traumatic Spinal Cord Injury in the United States: A National Inpatient Analysis.
  Crispo JAG, Liu LJW, Noonan VK, Thorogood NP, Kwon BK, Dvorak MF, Thibault D, Willis A, Cragg JJ Topics in spinal cord injury rehabilitation. 2022 Winter;28(1):1-12 Epub 2022 Jan 19;
• Geographic Barriers Drive Disparities in Specialty Center Access for Older Adults with Huntington's Disease.
  Pham Nguyen TP, Bravo L, Gonzalez-Alegre P, Willis AW Journal of Huntington's disease. 2022;11(1):81-89;
• Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study.
  Li R, Tropea TF, Baratta LR, Zuroff L, Diaz-Ortiz ME, Zhang B, Shinoda K, Rezk A, Alcalay RN, Chen-Plotkin A, Bar-Or A Neurology(R) neuroimmunology & neuroinflammation. 2022 Mar;9(2) Epub 2021 Dec 26;
• Resident & Fellow Rounds: December 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Dec 14;97(24):1132-1133;
• Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
  Jackson H, Anzures-Cabrera J, Taylor KI, Pagano G, PASADENA Investigators, Prasinezumab Study Group Frontiers in neuroscience. 2021;15:765765 Epub 2021 Dec 13;
• Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.
  Rodriguez-Sanchez F, Rodriguez-Blazquez C, Bielza C, Larrañaga P, Weintraub D, Martinez-Martin P, Rizos A, Schrag A, Chaudhuri KR Scientific reports. 2021 Dec 8;11(1):23645;
• Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion.
  Wang M, Sajobi T, Morgante F, Adler C, Agarwal P, Bäumer T, Berardelli A, Berman BD, Blumin J, Borsche M, Brashear A, Deik A, Duque K, Espay AJ, Ferrazzano G, Feuerstein J, Fox S, Frank S, Hallett M, Jankovic J, LeDoux MS, Leegwater-Kim J, Mahajan A, Malaty IA, Ondo W, Pantelyat A, Pirio-Richardson S, Roze E, Saunders-Pullman R, Suchowersky O, Truong D, Vidailhet M, Shukla AW, Perlmutter JS, Jinnah HA, Martino D European journal of neurology. 2021 Dec;28(12):3999-4009 Epub 2021 Aug 4;
• Quality of referrals for glaucoma assessment: a cross-sectional survey of clinical data and outcomes.
  Szulborski KJ, Weintraub DS, Roh S, Alwreikat AM, Cooper ML, Cotran PR, Ramsey DJ International ophthalmology. 2021 Dec;41(12):4065-4073 Epub 2021 Jul 30;
• Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
  Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2021 Dec;36(12):2945-2950 Epub 2021 Sep 4;
• Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.
  Sauerbier A, Loehrer P, Jost ST, Heil S, Petry-Schmelzer JN, Herberg J, Bachon P, Aloui S, Gronostay A, Klingelhoefer L, Baldermann JC, Huys D, Nimsky C, Barbe MT, Fink GR, Martinez-Martin P, Ray Chaudhuri K, Visser-Vandewalle V, Timmermann L, Weintraub D, Dafsari HS, EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group Journal of neurology, neurosurgery, and psychiatry. 2021 Dec;92(12):1313-1318 Epub 2021 Sep 11;
• Resident & Fellow Rounds: November 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Nov 30;97(22):1035-1038;
• Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
  Hutchison RM, Evans KC, Fox T, Yang M, Barakos J, Bedell BJ, Cedarbaum JM, Brys M, Siderowf A, Lang AE BMC neurology. 2021 Nov 23;21(1):459;
• Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment.
  Dobkin RD, Mann SL, Weintraub D, Rodriguez KM, Miller RB, St Hill L, King A, Gara MA, Interian A Movement disorders : official journal of the Movement Disorder Society. 2021 Nov;36(11):2549-2558 Epub 2021 Mar 12;
• The commercial genetic testing landscape for Parkinson's disease.
  Cook L, Schulze J, Verbrugge J, Beck JC, Marder KS, Saunders-Pullman R, Klein C, Naito A, Alcalay RN, ClinGen Parkinson's Disease Gene Curation Expert Panel and the MDS Task Force for Recommendations for Genetic Testing in Parkinson's Disease, Clinical Genome Resource (ClinGen) Parkinson's Disease Gene Curation Expert Panel Authors, Movement Society Disorder (MDS) Task Force on Recommendations for Clinical Genetic Testing in Parkinson's Disease Authors Parkinsonism & related disorders. 2021 Nov;92:107-111 Epub 2021 Oct 19;
• International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease.
  Laansma MA, Bright JK, Al-Bachari S, Anderson TJ, Ard T, Assogna F, Baquero KA, Berendse HW, Blair J, Cendes F, Dalrymple-Alford JC, de Bie RMA, Debove I, Dirkx MF, Druzgal J, Emsley HCA, Garraux G, Guimarães RP, Gutman BA, Helmich RC, Klein JC, Mackay CE, McMillan CT, Melzer TR, Parkes LM, Piras F, Pitcher TL, Poston KL, Rango M, Ribeiro LF, Rocha CS, Rummel C, Santos LSR, Schmidt R, Schwingenschuh P, Spalletta G, Squarcina L, van den Heuvel OA, Vriend C, Wang JJ, Weintraub D, Wiest R, Yasuda CL, Jahanshad N, Thompson PM, van der Werf YD, ENIGMA-Parkinson's Study Movement disorders : official journal of the Movement Disorder Society. 2021 Nov;36(11):2583-2594 Epub 2021 Jul 20;
• Palato-Pharyngo-Laryngeal Myoclonus with Facial Involvement After an Ischemic Stroke.
  Nathan CL, Quigley S, Spindler M Movement disorders clinical practice. 2022 Jan;9(1):104-106 Epub 2021 Oct 29;
• Resident & Fellow Rounds: October 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Oct 26;97(17):832-834;
• Videoconferencing Software Options for Telemedicine: A Review for Movement Disorder Neurologists.
  Cubo E, Arnaiz-Rodriguez A, Arnaiz-González Á, Díez-Pastor JF, Spindler M, Cardozo A, Garcia-Bustillo A, Mari Z, Bloem BR Frontiers in neurology. 2021;12:745917 Epub 2021 Oct 11;
• Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies.
  Campo MD, Pijnenburg YAL, Chen-Plotkin A, Irwin DJ, Grossman M, Twaalfhoven HAM, Hu WT, Meeter LH, van Swieten J, Vermunt L, Martens F, Heijboer AC, Teunissen CE Biomolecules. 2021 Oct 8;11(10);
• Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?
  Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW Movement disorders clinical practice. 2021 Nov;8(8):1181-1188 Epub 2021 Oct 8;
• Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
  Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B, Parkinson’s Progression Markers Initiative PloS one. 2021;16(10):e0257372 Epub 2021 Oct 7;
• Temporal trends and yield of clinical diagnostic genetic testing in adult neurology.
  Guo MH, Bardakjian TM, Brzozowski MR, Scherer SS, Quinn C, Elman L, Orthmann-Murphy J, Tropea TF, Ellis CA, Gonzalez-Alegre P American journal of medical genetics. Part A. 2021 Oct;185(10):2922-2928 Epub 2021 Jun 2;
• TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
  Mao F, Robinson JL, Unger T, Posavi M, Amado DA, Elman L, Grossman M, Wolk DA, Lee EB, Van Deerlin VM, Porta S, Lee VMY, Trojanowski JQ, Chen-Plotkin AS Acta neuropathologica. 2021 Oct;142(4):629-642 Epub 2021 Jun 21;
• Strengthened through Diversity: A Blueprint for Organizational Change.
  Willis A, Skolarus LE, Faigle R, Menon U, Redwine H, Brown AM, Felton E, Mendizabal A, Nath A, Jensen F, McArthur JC Annals of neurology. 2021 Oct;90(4):524-536 Epub 2021 Aug 5;
• Statins for the Prevention of Post-Stroke Seizure and Epilepsy Development: A Systematic Review and Meta-Analysis.
  Acton EK, Khazaal O, Willis AW, Gelfand MA, Hennessy S, Selim MH, Kasner SE Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2021 Oct;30(10):106024 Epub 2021 Aug 23;
• A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
  Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A, PASADENA Investigators, Prasinezumab Study Group Frontiers in neurology. 2021;12:705407 Epub 2021 Oct 1;
• Impact of ICD-9 to ICD-10 Coding Transition on Prevalence Trends in Neurology.
  Hamedani AG, Blank L, Thibault DP, Willis AW Neurology. Clinical practice. 2021 Oct;11(5):e612-e619;
• Resident & Fellow Rounds: September 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Sep 28;97(13):644-646;
• Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
  Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T JAMA. 2021 Sep 14;326(10):926-939;
• A Department Approach to Teleneurology.
  Spindler M, Jacobs D, Yuan K, Tropea T, Teng CW, Perrone C, Do D, Wechsler L Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2021 Sep;27(9):1078-1084 Epub 2020 Dec 18;
• Resident & Fellow Rounds: August 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Aug 31;97(9):445-448;
• Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
  Tropea TF, Chen-Plotkin A Journal of personalized medicine. 2021 Aug 25;11(9);
• Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis.
  Pham Nguyen TP, Leonard CE, Bird SJ, Willis AW, Hamedani AG Muscle & nerve. 2021 Aug;64(2):156-162 Epub 2021 Mar 26;
• Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease.
  Abraham DS, Pham Nguyen TP, Willis AW Movement disorders : official journal of the Movement Disorder Society. 2021 Aug;36(8):1871-1878 Epub 2021 Mar 23;
• Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
  Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, Hutten SJ, Dziadek S, Trenkwalder C, Pagano G, Mollenhauer B Movement disorders : official journal of the Movement Disorder Society. 2021 Aug;36(8):1972-1978 Epub 2021 May 4;
• Tau immunotherapy is associated with glial responses in FTLD-tau.
  Kim B, Mikytuck B, Suh E, Gibbons GS, Van Deerlin VM, Vaishnavi SN, Spindler MA, Massimo L, Grossman M, Trojanowski JQ, Irwin DJ, Lee EB Acta neuropathologica. 2021 Aug;142(2):243-257 Epub 2021 May 5;
• Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.
  Dratch L, Paul RA, Baldwin A, Brzozowski M, Gonzalez-Alegre P, Tropea TF, Raper A, Bardakjian T Journal of genetic counseling. 2021 Aug;30(4):974-983 Epub 2021 Jul 15;
• Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.
  Hsiao CT, Tropea TF, Fu SJ, Bardakjian TM, Gonzalez-Alegre P, Soong BW, Tang CY, Jeng CJ International journal of molecular sciences. 2021 Jul 31;22(15);
• Trial of Pimavanserin in Dementia-Related Psychosis.
  Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, Devanand DP, Weintraub D, McEvoy B, Youakim JM, Stankovic S, Foff EP The New England journal of medicine. 2021 Jul 22;385(4):309-319;
• Of mice and men: What a mouse model of microglial C9ORF72 deficiency does-and does not-tell us about human neurodegenerative diseases.
  Chen-Plotkin AS Neuron. 2021 Jul 21;109(14):2203-2204;
• Author Correction: Parkinson disease-associated cognitive impairment.
  Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D Nature reviews. Disease primers. 2021 Jul 13;7(1):53;
• Parkinson disease-associated cognitive impairment.
  Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D Nature reviews. Disease primers. 2021 Jul 1;7(1):47;
• Multiple sclerosis hospitalizations among users of oral disease-modifying therapies.
  Pham Nguyen TP, Jacobs D, Thibault D, Willis AW Multiple sclerosis and related disorders. 2021 Jul;52:102944 Epub 2021 Apr 20;
• Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?
  Pham Nguyen TP, Abraham DS, Thibault D, Weintraub D, Willis AW BMC neurology. 2021 Jun 24;21(1):240;
• Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
  Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS, EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group NPJ Parkinson's disease. 2021 Jun 8;7(1):48;
• Comparative neurological safety of fluoroquinolones versus therapeutic alternatives.
  Ellis DE, Hubbard RA, Willis AW, Zuppa AF, Zaoutis TE, Hennessy S Pharmacoepidemiology and drug safety. 2021 Jun;30(6):797-805 Epub 2021 Mar 23;
• Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease.
  Aamodt WW, Travers J, Thibault D, Willis AW The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 2021 Jun 1;53(3):116-122;
• L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma.
  Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJK, Lee JH, Chen-Plotkin AS, Regev A, Church GM, Walt DR Nature methods. 2021 Jun;18(6):631-634 Epub 2021 Jun 3;
• Movement in Aesthetic Experiences: What We Can Learn from Parkinson Disease.
  Humphries S, Rick J, Weintraub D, Chatterjee A Journal of cognitive neuroscience. 2021 Jun 1;33(7):1329-1342;
• Survival and Health Care Use After Deep Brain Stimulation for Parkinson's Disease.
  Crispo JAG, Lam M, Le B, Shariff SZ, Ansell DR, Squarzolo M, Ouellette D, Thibault DP, Marras C, Willis AW, Seitz D The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2021 May;48(3):372-382 Epub 2020 Aug 28;
• Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.
  Oikonomou P, van Wamelen DJ, Weintraub D, Aarsland D, Ffytche D, Martinez-Martin P, Rodriguez-Blazquez C, Leta V, Borley C, Sportelli C, Trivedi D, Podlewska AM, Rukavina K, Rizos A, Lazcano-Ocampo C, Ray Chaudhuri K Brain and behavior. 2021 May;11(5):e02086 Epub 2021 Mar 1;
• Prevalence and Risk Factors for Double Vision in Parkinson Disease.
  Hamedani AG, Maguire MG, Marras C, Willis AW Movement disorders clinical practice. 2021 Jul;8(5):709-712 Epub 2021 Apr 22;
• Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America.
  Naito A, Wills AM, Tropea TF, Ramirez-Zamora A, Hauser RA, Martino D, Turner TH, Rafferty MR, Afshari M, Williams KL, Vaou O, McKeown MJ, Ginsburg L, Ezra A, Iansek R, Wallock K, Evers C, Schroeder K, DeLeon R, Yarab N, Alcalay RN, Beck JC NPJ Parkinson's disease. 2021 Apr 12;7(1):34;
• Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease.
  Hulshoff MJ, Book E, Dahodwala N, Tanner CM, Robertson C, Marras C Movement disorders clinical practice. 2021 May;8(4):510-520 Epub 2021 Apr 12;
• Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
  Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KAQ Neurology. 2021 Apr 6;96(14):e1855-e1864 Epub 2021 Feb 16;
• Author Correction: A growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology.
  Wie J, Liu Z, Song H, Tropea TF, Yang L, Wang H, Liang Y, Cang C, Aranda K, Lohmann J, Yang J, Lu B, Chen-Plotkin AS, Luk KC, Ren D Nature. 2021 Apr;592(7855):E10;
• Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.
  Zhang JV, Irwin DJ, Blennow K, Zetterberg H, Lee EB, Shaw LM, Rascovsky K, Massimo L, McMillan CT, Chen-Plotkin A, Elman L, Lee VM, McCluskey L, Toledo JB, Weintraub D, Wolk D, Trojanowski JQ, Grossman M Neurology. Clinical practice. 2021 Apr;11(2):105-116;
• A nationwide analysis of maternal morbidity and acute postpartum readmissions in women with epilepsy.
  Decker BM, Thibault D, Davis KA, Willis AW Epilepsy & behavior : E&B. 2021 Apr;117:107874 Epub 2021 Mar 8;
• Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
  Simuni T, Fiske B, Merchant K, Coffey CS, Klingner E, Caspell-Garcia C, Lafontant DE, Matthews H, Wyse RK, Brundin P, Simon DK, Schwarzschild M, Weiner D, Adams J, Venuto C, Dawson TM, Baker L, Kostrzebski M, Ward T, Rafaloff G, Parkinson Study Group NILO-PD Investigators and Collaborators JAMA neurology. 2021 Mar 1;78(3):312-320;
• A growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology.
  Wie J, Liu Z, Song H, Tropea TF, Yang L, Wang H, Liang Y, Cang C, Aranda K, Lohmann J, Yang J, Lu B, Chen-Plotkin AS, Luk KC, Ren D Nature. 2021 Mar;591(7850):431-437 Epub 2021 Jan 27;
• Resident & Fellow Rounds.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Feb 23;96(8):396-398;
• Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study.
  Roberts AC, Rafferty MR, Wu SS, Miao G, Cubillos F, Simuni T, Parkinson's Foundation Quality Improvement Initiative Investigators Steering Committee Members, PF QII Principal Investigators Parkinsonism & related disorders. 2021 Feb;83:115-122 Epub 2020 Dec 4;
• LRRK2 and survival in progressive supranuclear palsy.
  Chen-Plotkin AS The Lancet. Neurology. 2021 Feb;20(2):83-84 Epub 2020 Dec 17;
• Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease.
  Forbes E, Tropea TF, Mantri S, Xie SX, Morley JF Movement disorders clinical practice. 2021 Feb;8(2):254-263 Epub 2021 Jan 20;
• Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults.
  Blank LJ, Acton EK, Thibault D, Willis AW Age and ageing. 2021 Jan 8;50(1):205-212;
• Predictors of Mortality in Older Adults With Epilepsy: Implications for Learning Health Systems.
  Blank LJ, Acton EK, Willis AW Neurology. 2021 Jan 5;96(1):e93-e101 Epub 2020 Oct 21;
• Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
  Leta V, Urso D, Batzu L, Weintraub D, Titova N, Aarsland D, Martinez-Martin P, Borghammer P, van Wamelen DJ, Yousaf T, Rizos A, Rodriguez-Blazquez C, Chung-Faye G, Chaudhuri KR Journal of Parkinson's disease. 2021;11(3):1209-1219;
• Assessment of Affective-Behavioral States in Parkinson's Disease Patients: Towards a New Screening Tool.
  Schedlich-Teufer C, Jost ST, Krack P, Witt K, Weintraub D, Baldermann JC, Sommerauer M, Amstutz D, van Eimeren T, Dafsari HS, Kalbe E, Visser-Vandewalle V, Fink GR, Kessler J, Barbe MT Journal of Parkinson's disease. 2021;11(3):1417-1430;
• Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson's Disease.
  Di Luca DG, McArthur EW, Willis A, Martino R, Marras C Journal of Parkinson's disease. 2021;11(4):1965-1971;
• Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
  Gupta HV, Beach TG, Mehta SH, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Liebsack C, Dugger BN, Serrano GE, Sue LI, Siderowf A, Pontecorvo MJ, Mintun MA, Joshi AD, Adler CH Journal of Alzheimer's disease : JAD. 2021;80(4):1603-1612;
• Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease.
  Abraham DS, Pham Nguyen TP, Hennessy S, Gray SL, Xie D, Weintraub D, Willis AW The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2021 Jan;29(1):35-47 Epub 2020 May 18;
• Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
  Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodríguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C Journal of Parkinson's disease. 2021;11(2):395-404;
• Differences in the Presentation and Progression of Parkinson's Disease by Sex.
  Iwaki H, Blauwendraat C, Leonard HL, Makarious MB, Kim JJ, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Smolensky L, Amondikar N, Hutten SJ, Frasier M, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Gibbs RJ, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Andreassen OA, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA Movement disorders : official journal of the Movement Disorder Society. 2021 Jan;36(1):106-117 Epub 2020 Oct 1;
• The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use.
  van Wamelen DJ, Martinez-Martin P, Weintraub D, Schrag A, Antonini A, Falup-Pecurariu C, Odin P, Ray Chaudhuri K, International Parkinson and Movement Disorder Society Parkinson's Disease Non-Motor Study Group Acta neurologica Scandinavica. 2021 Jan;143(1):3-12 Epub 2020 Sep 29;
• A Model to Assess the Outcomes Associated With Dementia With Lewy Bodies.
  Espinosa R, Davis M, Johnson S, Cline S, Weintraub D Alzheimer disease and associated disorders. 2021 Jan-Mar 01;35(1):68-74;
• Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population.
  Dahodwala N, Li P, Jahnke J, Ladage VP, Pettit AR, Kandukuri PL, Bao Y, Zamudio J, Jalundhwala YJ, Doshi JA Movement disorders : official journal of the Movement Disorder Society. 2021 Jan;36(1):133-142 Epub 2020 Oct 8;
• Inconsistent reporting of drug-drug interactions for hormonal contraception and antiepileptic drugs - Implications for reproductive health for women with epilepsy.
  Decker BM, Acton EK, Davis KA, Willis AW Epilepsy & behavior : E&B. 2021 Jan;114(Pt A):107626 Epub 2020 Dec 9;
• PPP2R5D Genetic Mutations and Early-Onset Parkinsonism.
  Walker IM, Riboldi GM, Drummond P, Saade-Lemus S, Martin-Saavedra JS, Frucht S, Bardakjian TM, Gonzalez-Alegre P, Deik A Annals of neurology. 2021 Jan;89(1):194-195 Epub 2020 Nov 5;
• Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries.
  Dahodwala N, Jahnke J, Pettit AR, Li P, Ladage VP, Kandukuri PL, Bao Y, Zamudio J, Jalundhwala YJ, Doshi JA Journal of Parkinson's disease. 2021;11(2):675-684;
• Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder.
  Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A Annals of clinical and translational neurology. 2021 Jan;8(1):201-212 Epub 2020 Dec 15;
• Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
  Gallagher J, Rick J, Xie SX, Martinez-Martin P, Mamikonyan E, Chen-Plotkin A, Dahodwala N, Morley J, Duda JE, Trojanowski JQ, Siderowf A, Weintraub D Journal of Parkinson's disease. 2021;11(2):737-745;
• Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study.
  Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, Willis AW, Van Deerlin V, Chen-Plotkin A Journal of Parkinson's disease. 2021;11(2):757-765;
• Global Perspective on Telemedicine for Parkinson's Disease.
  Shalash A, Spindler M, Cubo E Journal of Parkinson's disease. 2021;11(s1):S11-S18;
• Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
  Devous MD Sr, Fleisher AS, Pontecorvo MJ, Lu M, Siderowf A, Navitsky M, Kennedy I, Southekal S, Harris TS, Mintun MA Journal of Alzheimer's disease : JAD. 2021;80(3):1091-1104;
• Prevalence of Non-Motor Symptoms and Non-Motor Fluctuations in Parkinson's Disease Using the MDS-NMS.
  Rodriguez-Blazquez C, Schrag A, Rizos A, Chaudhuri KR, Martinez-Martin P, Weintraub D Movement disorders clinical practice. 2021 Feb;8(2):231-239 Epub 2020 Dec 21;

See full pubmed publications list